{
    "nct_id": "NCT03665584",
    "official_title": "A Double Blinded Sham Controlled Trial of Fractional CO2 Laser Treatment Using the DEKA SmartXide Touch Laser System (MonaLisa Touch) for the Treatment of Vulvar Lichen Sclerosus",
    "inclusion_criteria": "* Are 18 years or older.\n* Have a diagnosis of active lichen sclerosus (Dr. Goldstein will remove a pea size amount of skin (a biopsy) and will do a physical assessment of the vulva area at the beginning of the study to confirm this diagnosis).\n* Are willing and able to comply with the study requirements.\n* Have a negative pregnancy test prior to enrolling in this study and will use at least one form of birth control during the course of the study if you are sexually active and are of child bearing potential.\n* Have at least a 3 out of 10 on a questionnaire that measures the amount of itching you are having.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Are immunocompromised (have a lowered immune system) (for example, you have been diagnosed with or have a history of lymphoma, AIDS, or Wiskott-Aldrich Syndrome), or have an uncontrolled malignant disease.\n* Have a generalized infection (bacterial, viral or fungal), or obvious localized infections in the vulva area.\n* Have swollen lymph nodes (lymphadenopathy).\n* Have any active sexually transmitted diseases on the vulva (herpes, molluscum, condyloma).\n* Have been diagnosed with other vulvar dermatologic conditions including lichen planus, psoriasis, lichen simplex chronicus, candidiasis, intraepithelial neoplasia, or carcinoma.\n* Are pregnant or breastfeeding.\n* If you become pregnant while on the study, you must withdraw from the study.\n* Have received an investigational drug within four weeks prior to the study or who plan to use other investigational drugs during the course of this study.\n* Have severe medical condition(s) that in the view of the study doctor prohibits participation in the study.\n* Have a history of substance abuse or any factor, which limits your ability to cooperate with the study procedures.\n* Are uncooperative or are not willing to attend regular visits.\n* Have received systemic immunosuppressants (steroids), other systemic therapies or any other systemic therapies known or suspected to have an effect on vulvar lichen sclerosus within 4 weeks prior to participation in the study.\n* Have been treated with topical therapy (for example, topical corticosteroids, pimecrolimus, tacrolimus) or any other topical therapies known or suspected to have an effect on vulvar lichen sclerosus or its symptoms within 4 weeks prior to participation in the study.",
    "miscellaneous_criteria": ""
}